• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体诱导的长链非编码RNA SOX2-OT通过靶向miR-320a-5p-CCR5轴促进三阴性乳腺癌的肿瘤发生。

Androgen receptor-induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p-CCR5 axis.

作者信息

Hu Yixuan, Bian Jin, Chen Weiwei, Shi Junfeng, Wei Xiaowei, Du Yueyao, Zhang Wenwen

机构信息

Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Department of Medical Oncology of PLA Cancer Center, Jinling Hospital, Nanjing, China.

出版信息

J Biol Chem. 2025 Apr;301(4):108428. doi: 10.1016/j.jbc.2025.108428. Epub 2025 Mar 19.

DOI:10.1016/j.jbc.2025.108428
PMID:40118451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12017981/
Abstract

Our previous study showed that androgen receptor (AR) promotes triple-negative breast cancer (TNBC) cell tumorigenesis, but the underlying mechanisms remain unclear. Herein, using microarray analysis of long noncoding RNA expression profiles, we identified an AR-related long noncoding RNA SOX2-OT in TNBC. We found that AR could promote TNBC tumorigenesis by acting as a transcription factor to activate the expression of SOX2-OT. Mechanistic analysis demonstrated that SOX2-OT serves as a molecular sponge for miR-320a-5p to regulate the expression of CCR5. In addition, SOX2-OT promotes TNBC cell proliferation and inhibits apoptosis in an miR-320a-5p-dependent manner. Using a xenograft mouse model, we found that SOX2-OT-CCR5 axis could promote TNBC tumorigenesis in vivo. Importantly, the AR-SOX2-OT-miR-320a-5p-CCR5 axis is manifested in the tissues of 165 TNBC patients. Collectively, our results suggest that SOX2-OT can regulate AR-induced TNBC tumorigenesis through the miR-320a-5p-CCR5 signaling axis and reveal the great potential of targeting SOX2-OT for the treatment of TNBC patients.

摘要

我们之前的研究表明,雄激素受体(AR)可促进三阴性乳腺癌(TNBC)细胞的肿瘤发生,但其潜在机制仍不清楚。在此,通过对长链非编码RNA表达谱进行微阵列分析,我们在TNBC中鉴定出一种与AR相关的长链非编码RNA SOX2-OT。我们发现,AR可作为转录因子激活SOX2-OT的表达,从而促进TNBC的肿瘤发生。机制分析表明,SOX2-OT作为miR-320a-5p的分子海绵来调节CCR5的表达。此外,SOX2-OT以miR-320a-5p依赖的方式促进TNBC细胞增殖并抑制细胞凋亡。利用异种移植小鼠模型,我们发现SOX2-OT-CCR5轴可在体内促进TNBC的肿瘤发生。重要的是,AR-SOX2-OT-miR-320a-5p-CCR5轴在165例TNBC患者的组织中得到证实。总体而言,我们的结果表明,SOX2-OT可通过miR-320a-5p-CCR5信号轴调节AR诱导的TNBC肿瘤发生,并揭示了靶向SOX2-OT治疗TNBC患者的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/39512460f85b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/6bf290ba8890/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/7ff50608043e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/27fc0101dec4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/8dc6667e2d70/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/47f10716e583/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/39512460f85b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/6bf290ba8890/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/7ff50608043e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/27fc0101dec4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/8dc6667e2d70/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/47f10716e583/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f111/12017981/39512460f85b/gr6.jpg

相似文献

1
Androgen receptor-induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p-CCR5 axis.雄激素受体诱导的长链非编码RNA SOX2-OT通过靶向miR-320a-5p-CCR5轴促进三阴性乳腺癌的肿瘤发生。
J Biol Chem. 2025 Apr;301(4):108428. doi: 10.1016/j.jbc.2025.108428. Epub 2025 Mar 19.
2
SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.PAI-1 诱导的 SOX2-OT 通过海绵吸附 miR-942-5p 并激活 PI3K/Akt 信号通路促进三阴性乳腺癌细胞转移。
Cell Mol Life Sci. 2022 Jan 7;79(1):59. doi: 10.1007/s00018-021-04120-1.
3
LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.长链非编码 RNA DANCR 通过 TUFT1 上调促进三阴性乳腺癌的恶性进展,通过 miR-874-3p-SOX2 轴。
Exp Cell Res. 2020 Nov 15;396(2):112331. doi: 10.1016/j.yexcr.2020.112331. Epub 2020 Oct 13.
4
LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.长链非编码 RNA DLX6-AS1 通过调节 Mir-199b-5p/桩蛋白轴促进三阴性乳腺癌中的上皮-间质转化和顺铂耐药。
Cell Transplant. 2020 Jan-Dec;29:963689720929983. doi: 10.1177/0963689720929983.
5
LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis.长链非编码RNA MCM3AP-AS1通过miR-524-5p/RBM39轴促进三阴性乳腺癌的化疗耐药性。
Mol Cell Biochem. 2025 Jan;480(1):371-384. doi: 10.1007/s11010-023-04908-8. Epub 2024 Mar 12.
6
Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.长链非编码RNA linc00921通过靶向miR-9-5p/LZTS2轴抑制三阴性乳腺癌的肿瘤发生和上皮-间质转化。
Hum Cell. 2022 May;35(3):909-923. doi: 10.1007/s13577-022-00685-6. Epub 2022 Feb 18.
7
LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth.长链非编码 RNA SOX2-OT 通过调控 miR-192-5p/RAB2A 轴和 ERK 通路促进胶质母细胞瘤细胞生长。
Cell Cycle. 2021 Oct;20(19):2010-2020. doi: 10.1080/15384101.2021.1965722. Epub 2021 Sep 1.
8
miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.miR-574-5p 通过靶向 BCL11A 和 SOX2 抑制 SKIL/TAZ/CTGF 轴来抑制三阴性乳腺癌细胞的增殖、迁移和 EMT。
Int J Oncol. 2020 May;56(5):1240-1251. doi: 10.3892/ijo.2020.4995. Epub 2020 Feb 20.
9
LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.长链非编码 RNA WEE2-AS1 通过调控 miR-32-5p/TOB1 轴促进三阴性乳腺癌细胞的增殖并抑制凋亡。
Biochem Biophys Res Commun. 2020 Jun 11;526(4):1005-1012. doi: 10.1016/j.bbrc.2020.01.170. Epub 2020 Apr 16.
10
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.长链非编码 RNA HCP5 通过海绵吸附 miR-219a-5p 调控 BIRC3 促进三阴性乳腺癌进展。
Cancer Med. 2019 Aug;8(9):4389-4403. doi: 10.1002/cam4.2335. Epub 2019 Jun 18.

引用本文的文献

1
Advances of androgen receptor in triple-negative breast cancer: from molecular mechanisms to clinical applications.雄激素受体在三阴性乳腺癌中的研究进展:从分子机制到临床应用
Discov Oncol. 2025 Sep 3;16(1):1677. doi: 10.1007/s12672-025-03431-0.

本文引用的文献

1
Platinum-based systematic therapy in triple-negative breast cancer.三阴性乳腺癌的铂类全身治疗
Biochim Biophys Acta Rev Cancer. 2022 Jan;1877(1):188678. doi: 10.1016/j.bbcan.2022.188678. Epub 2022 Jan 10.
2
SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.PAI-1 诱导的 SOX2-OT 通过海绵吸附 miR-942-5p 并激活 PI3K/Akt 信号通路促进三阴性乳腺癌细胞转移。
Cell Mol Life Sci. 2022 Jan 7;79(1):59. doi: 10.1007/s00018-021-04120-1.
3
Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.
三阴性乳腺癌的治疗现状——选择增多,需求变化。
Nat Rev Clin Oncol. 2022 Feb;19(2):91-113. doi: 10.1038/s41571-021-00565-2. Epub 2021 Nov 9.
4
Progress and challenges of immunotherapy in triple-negative breast cancer.三阴性乳腺癌免疫治疗的进展与挑战。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188593. doi: 10.1016/j.bbcan.2021.188593. Epub 2021 Jul 17.
5
Long noncoding RNAs in cancer metastasis.长非编码 RNA 在癌症转移中的作用。
Nat Rev Cancer. 2021 Jul;21(7):446-460. doi: 10.1038/s41568-021-00353-1. Epub 2021 May 5.
6
Hormonal Therapy for Prostate Cancer.前列腺癌的激素治疗。
Endocr Rev. 2021 May 25;42(3):354-373. doi: 10.1210/endrev/bnab002.
7
Gene regulation by long non-coding RNAs and its biological functions.长非编码 RNA 的基因调控及其生物学功能。
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118. doi: 10.1038/s41580-020-00315-9. Epub 2020 Dec 22.
8
The long non-coding RNA landscape in triple-negative breast cancer.三阴性乳腺癌中的长非编码 RNA 全景。
Cell Prolif. 2021 Feb;54(2):e12966. doi: 10.1111/cpr.12966. Epub 2020 Dec 13.
9
Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative.转移性三阴性乳腺癌的新型治疗药物:在阴性中寻找阳性
J Natl Compr Canc Netw. 2020 Oct 15:1-9. doi: 10.6004/jnccn.2020.7600.
10
Epigenetic Regulation of by Drives Metastatic Progression in Triple-Negative Breast Cancer.通过 驱动的 表观遗传调控促进三阴性乳腺癌的转移进展。
Cancer Res. 2019 Jul 1;79(13):3347-3359. doi: 10.1158/0008-5472.CAN-18-3418. Epub 2019 Apr 2.